Precision Biosciences (DTIL) Capital Expenditures (2018 - 2026)
Precision Biosciences (DTIL) reported Capital Expenditures of $18000.0 for Q1 2026, down 71.88% year-over-year from $64000.0 in Q1 2025, and down 5.26% quarter-over-quarter from $19000.0 in Q4 2025.
Precision Biosciences (DTIL) Capital Expenditures (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Capital Expenditures data on file, last reported at $18000.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $18000.0, down 71.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $39000.0 (down 82.89% YoY), and the FY2025 annual result was $85000.0, down 66.0% from the prior year.
- Capital Expenditures eased to $18000.0 in Q1 2026 per DTIL's latest filing, from $19000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.1 million in Q3 2022 and troughed at -$26000.0 in Q4 2023.
- A 5-year average of $351812.5 and a median of $91500.0 in 2024 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2023 and 2024: Capital Expenditures tumbled 104.11% in 2023, then surged 473.08% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $632000.0 in 2022, then sank by 104.11% to -$26000.0 in 2023, then surged by 473.08% to $97000.0 in 2024, then plunged by 80.41% to $19000.0 in 2025, then retreated by 5.26% to $18000.0 in 2026.
- Business Quant data shows DTIL's Capital Expenditures at $18000.0 in Q1 2026, $19000.0 in Q4 2025, and $2000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -63,220.27 |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,000.00 |
| Mar 31, 2026 | 18,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Dec 31, 2025 | 19,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Mar 31, 2025 | 64,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Mar 31, 2024 | 86,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Sep 30, 2023 | 386,000.00 |
| Sep 30, 2023 | 386,000.00 |